In the FSP1 null mouse model, the mice instead display significantly delayed and decreased tumor initiation upon injection of highly metastatic mouse mammary carcinoma cells, whereas the co-injection with FSP1-positive fibroblasts restores tumor development and enhances metastasis [82]. This evidence concerns the gene S100A4 and breast carcinoma.